Clinical development of two innovative pharmaceutical forms of leuprorelin acetate.
- Published in:
- Therapeutic Advances in Urology, 2013, v. 5, n. 1, p. 3, doi. 10.1177/1756287212471096
- By:
- Publication type:
- Article
Works matching IS 17562872 AND DT 2013 AND VI 5 AND IP 1
Results: 7
1
2
Acknowledgements.
- Published in:
- Therapeutic Advances in Urology, 2013, v. 5, n. 1, p. 67, doi. 10.1177/1756287212469595
- Publication type:
- Article
3
Experience with degarelix in the treatment of prostate cancer.
- Published in:
- Therapeutic Advances in Urology, 2013, v. 5, n. 1, p. 11, doi. 10.1177/1756287212461048
- By:
- Publication type:
- Article
4
Experience with imidafenacin in the management of overactive bladder disorder.
- Published in:
- Therapeutic Advances in Urology, 2013, v. 5, n. 1, p. 43, doi. 10.1177/1756287212459549
- By:
- Publication type:
- Article
5
Penile traction therapy and Peyronie’s disease: a state of art review of the current literature.
- Published in:
- Therapeutic Advances in Urology, 2013, v. 5, n. 1, p. 59, doi. 10.1177/1756287212454932
- By:
- Publication type:
- Article
6
Carbogen gas and radiotherapy outcomes in prostate cancer.
- Published in:
- Therapeutic Advances in Urology, 2013, v. 5, n. 1, p. 25, doi. 10.1177/1756287212452195
- By:
- Publication type:
- Article
7
Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties.
- Published in:
- Therapeutic Advances in Urology, 2013, v. 5, n. 1, p. 35, doi. 10.1177/1756287212466282
- By:
- Publication type:
- Article